A Scoping Review of Endoscopic Assessment Considering Disease Extent in Ulcerative Colitis: Insights for the Artificial Intelligence Era [0.03%]
内镜评估溃疡性结肠炎病变范围的文献综述：人工智能时代的启示
Yasuharu Maeda,Shin-Ei Kudo,Takanori Kuroki et al.
Yasuharu Maeda et al.
Conventional endoscopic indices for ulcerative colitis (UC) primarily assess the most severely affected segment, potentially underestimating the cumulative inflammatory burden across the colon. Consequently, there is increasing interest in ...
Muscle Mass as a Causal Factor in MASLD: Insights from a Genome-Wide Association Study and Bidirectional Mendelian Randomization Using Data from the Korean Genome and Epidemiology Study [0.03%]
基于韩国基因组和流行病学研究的全基因组关联研究和双向孟德尔随机化：肌肉质量在MASLD因果因素中的作用
Kiook Baek,Jung Gil Park,Yu Rim Lee et al.
Kiook Baek et al.
Background/aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is an emerging global health concern due to its increasing prevalence and associated risk of severe complications. Although body compositio...
Fibroblast Heterogeneity in Colorectal Cancer: Insights from Integrative Single-Cell Transcriptomics [0.03%]
结直肠癌中成纤维细胞异质性的单细胞转录组整合分析给出了新见解
Aras A Abdulla
Aras A Abdulla
Diabetes Duration, Severity, and the Risk of Gastrointestinal Bleeding: What the Gut Tells Us about Glucose [0.03%]
糖尿病病程、严重程度与消化道出血风险的关系：肠道告诉我们的关于血糖的事情
Kai-Liang Lin,Yen-Po Wang
Kai-Liang Lin
Esophageal Remodeling in Eosinophilic Esophagitis: Clinical and Functional Implications [0.03%]
嗜酸细胞性食管炎的食管重塑：临床和功能意义
Kee Wook Jung
Kee Wook Jung
Novel Efferocytosis-Related Prognostic Signature for Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization [0.03%]
用于经动脉化疗栓塞治疗的肝细胞癌患者的新凋亡相关预后标志物
Xiangpang Xie,Bingru Zheng
Xiangpang Xie
Background/aims: Transarterial chemoembolization (TACE) is a key treatment for hepatocellular carcinoma (HCC). However, patient outcomes after TACE are heterogeneous, and robust prognostic biomarkers are needed. This stud...
High Cardiometabolic Risk Burden Predicts Adverse Outcomes in Patients with MASLD-Related Hepatocellular Carcinoma [0.03%]
高心血管代谢风险负担预测MASLD相关肝细胞癌患者的不良预后
Yeonhong Do,Young Hyeon Ahn,Young Chang et al.
Yeonhong Do et al.
Background/aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a rapidly growing cause of hepatocellular carcinoma (HCC); however, the prognostic implications of the cumulative cardiometabolic risk f...
Risk of Gastric Neoplasms in Patients with Autoimmune Gastritis: A Systematic Review and Meta-Analysis [0.03%]
自身免疫性胃炎患者患胃肿瘤的风险：系统回顾和荟萃分析
Yong Hwan Ahn,Tae-Se Kim,Min-Ji Kim et al.
Yong Hwan Ahn et al.
Background/aims: Autoimmune gastritis (AIG) underlies type 1 gastric neuroendocrine tumors (NETs) and pernicious anemia (PA), a late-stage manifestation of AIG. Although PA is a risk factor for gastric cancer (GC), the in...
Review
Gut and liver. 2026 May 6. DOI:10.5009/gnl250515 2026
The Chronic Hepatitis B and Metabolic Dysfunction-Associated Steatotic Liver Disease Paradox: Friend or Foe? [0.03%]
慢性乙型肝炎与代谢功能障碍相关脂肪性肝病的悖论：是敌还是友？
Shang-Chin Huang,Tai-Chung Tseng
Shang-Chin Huang
Chronic hepatitis B (CHB) and metabolic dysfunction-associated steatotic liver disease (MASLD) frequently coexist, yet their interplay remains complex and paradoxical. Emerging evidence suggests that hepatic steatosis may suppress hepatitis...